Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROTAVAC and ROTAVAC 5D in healthy Zambian infants
NCT03602053Phase 3Completed
- Sponsor
- Center for Infectious Disease Research in Zambia
- Start
- Jan 2019
- Primary completion
- Oct 2019
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of rotavirus vaccine (live attenuated, oral) and rotavirus vaccine, live, oral, pentavalent in rotavirus infection, sponsored by Center for Infectious Disease Research in Zambia. Started Jan 2019; status: completed.
02
Drugs
rotavirus vaccine (live attenuated, oral)rotavirus vaccine, live, oral, pentavalent
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT03602053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03602053.